LOS ANGELES, Jan. 24, 2024 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services, today announces that its joint ventured Arizona Diagnostic Radiology Group, LLC (“Arizona Diagnostic Radiology”) has acquired seven outpatient imaging centers in Phoenix Arizona from Evernorth Care Group.
The acquisition will expand outpatient imaging services for Evernorth Care Group patients, who will now have access to Arizona Diagnostic Radiology’s nine additional imaging centers in the Phoenix market. Additionally, the newly acquired imaging centers will implement RadNet’s digital health solutions, including radiology information and image management systems and DeepHealth’s artificial intelligence platform. These solutions are focused on optimizing operational workflow, improving the patient experience and driving accuracy and earlier detection.
“Since we entered the Arizona marketplace at the end of 2020, we have been committed to growing scale and expanding patient access and services. This acquisition moves us further in the direction of achieving the patient access and breadth of services that we strive for in all of our core markets. We look forward to providing leading-edge technology and additional specialized imaging services in oncology, musculoskeletal, cardiac and vascular and neuroscience to the patients of Evernorth Care Group,” said RadNet President and Chief Executive Officer, Howard Berger, M.D.
“Driven by our commitment to provide high-quality care and convenience for our patients, we continually review and expand our services to ensure they are best positioned to meet patients’ needs,” said Jeff Holt, President, Evernorth Care Group. “Arizona Diagnostic Radiology has been a partner since June 2022, providing radiologists to supervise, interpret and deliver diagnostic support. Through acquiring our radiology service line, Arizona Diagnostic Radiology will now provide imaging services in our care locations and bring their established leadership and best-in-class capabilities to support a holistic, high-quality imaging program that helps improve health outcomes for our patients.”
About RadNet, Inc.
RadNet, Inc., is the leading national provider of freestanding, fixed-site diagnostic imaging services and related information technology solutions (including artificial intelligence) in the United States based on the number of locations and annual imaging revenue. RadNet has a network of 366 owned and/or operated outpatient imaging centers. RadNet's markets include California, Maryland, Delaware, New Jersey, New York, Florida and Arizona. Together with affiliated radiologists, including full-time and per diem employees and technologists, RadNet has approximately 9,000 employees. For more information, visit http://www.radnet.com
Mark Stolper
Executive Vice President and Chief Financial Officer
RadNet, Inc.
310-445-2800
Last Trade: | US$81.82 |
Daily Change: | -0.34 -0.41 |
Daily Volume: | 63,092 |
Market Cap: | US$6.050B |
November 11, 2024 November 10, 2024 November 07, 2024 September 17, 2024 September 12, 2024 |
Chimerix is on a mission to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases. The company is devoted to filling gaps in the treatment paradigm. Chimerix’s most advanced clinical-stage program is in development for H3 K27M-mutant glioma....
CLICK TO LEARN MOREImmix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...
CLICK TO LEARN MOREEnd of content
No more pages to load
COPYRIGHT ©2023 HEALTH STOCKS HUB